Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-07

Clinical Trial Update: Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan)

View source ↗

Summary

A post-marketing commitment trial update for Lyrica assessing safety and efficacy in neuralgia; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lyrica (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Neuralgia | Status: COMPLETED | Results posted: 2019-05-07